Pharmacists in Sheffield, AL Accepting Medicare
11 Pharmacists found. Showing 1 - 11
 Mr. Jeffrey W Frazee, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 507 N Columbia Ave, Sheffield, AL 35660 Phone: 256-381-4311 Fax: 256-383-0906 |
 Dr. Keri Ann Jones, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1300 S Montgomery Ave, Sheffield, AL 35660 Phone: 256-386-4084 |
Cara Pettus, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 805 S Montgomery Ave, Sheffield, AL 35660 Phone: 256-383-1970 |
Mrs. Susan Mitchell Balch, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 805 S Montgomery Ave, Rite-aid 07051, Sheffield, AL 35660 Phone: 256-383-1970 |
Mr. Timothy Alan Aaron, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 S Montgomery Ave, Suite 108, Sheffield, AL 35660 Phone: 256-389-9900 |
Jacqueline Jessica Sharp Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 805 S Montgomery Ave, Sheffield, AL 35660 Phone: 256-383-1970 |
Dr. Kyle Myhan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 805 S Montgomery Ave, Sheffield, AL 35660 Phone: 256-383-1970 |
Mr. Mike Kessler, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 507 N Columbia Ave, Sheffield, AL 35660 Phone: 256-381-4311 Fax: 256-386-0903 |
Dr. Matthew Shane Montgomery, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1300 S Montgomery Ave, Sheffield, AL 35660 Phone: 256-386-4084 |
Dr. Tabitha Michelle Seaman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 805 S Montgomery Ave, Sheffield, AL 35660 Phone: 256-383-1970 |
Mr. James Harry Grisham, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 805 S Montgomery Ave, Sheffield, AL 35660 Phone: 256-383-1970 |
News Archive
Pivotal trial of Elios melanoma vaccine to be conducted at top U.S. cancer hospitals
Elios Therapeutics, LLC recently received FDA approval of its Investigational New Drug (IND) application and its randomized phase IIb trial planned to enroll 120 stage III and IV (resected) melanoma patients to assess the ability of a personalized vaccine to prevent recurrence.
Lilly suspends tasisulam global Phase III study in metastatic melanoma
Eli Lilly and Company announced today that it has suspended its global Phase III study evaluating tasisulam, an investigational, small-molecule anti-cancer compound, as a second-line treatment for those with unresectable or metastatic melanoma.
Abnormal clock gene coordination observed in tissues of Alzheimer's patients
Twenty-four hour cycles, known as circadian rhythms, are important for proper body functions, including for normal brain function and mental health. Disruptions of circadian rhythms and sleep-wake cycles have been observed in patients with Alzheimer's disease. A new study by Douglas Institute researchers unravels a possible basis for these perturbations.
Meridian Health Plan named one of 'Best and Brightest Companies to Work For'
Meridian Health Plan, for the second time, has been nationally named one of the "Best and Brightest Companies to Work For" by the National Association for Business Resources. Previously, the NABR had consistently named Meridian as one of "Metropolitan Detroit's 101 Best and Brightest Companies to Work For" 2012 through 2015.
Mother's Day can be tough when your Mum has cancer
This May, in the spirit of Mother's Day, youth cancer charity CanTeen reaches out to the 15,000 Australians aged 12-24 years who have a parent diagnosed with cancer each year.
› Verified 7 days ago